Hassanein, T., McClain, C. J., Vatsalya, V., Stein, L. L., Flamm, S. L., Martin, P., . . . Lin, W. (2024). Safety, Pharmacokinetics, & Efficacy Signals of Larsucosterol (DUR-928) in Alcohol-associated Hepatitis. The American journal of gastroenterology, 119(1), 107-115. https://doi.org/10.14309/ajg.0000000000002275
Chicago Style (17th ed.) CitationHassanein, Tarek, et al. "Safety, Pharmacokinetics, & Efficacy Signals of Larsucosterol (DUR-928) in Alcohol-associated Hepatitis." The American Journal of Gastroenterology 119, no. 1 (2024): 107-115. https://doi.org/10.14309/ajg.0000000000002275.
MLA (9th ed.) CitationHassanein, Tarek, et al. "Safety, Pharmacokinetics, & Efficacy Signals of Larsucosterol (DUR-928) in Alcohol-associated Hepatitis." The American Journal of Gastroenterology, vol. 119, no. 1, 2024, pp. 107-115, https://doi.org/10.14309/ajg.0000000000002275.